Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Short-term Investments (2024 - 2025)

Allarity Therapeutics' Short-term Investments history spans 2 years, with the latest figure at $83000.0 for Q4 2025.

  • For Q4 2025, Short-term Investments rose 15.28% year-over-year to $83000.0; the TTM value through Dec 2025 reached $83000.0, up 15.28%, while the annual FY2025 figure was $83000.0, 15.28% up from the prior year.
  • Short-term Investments reached $83000.0 in Q4 2025 per ALLR's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $2.5 million in Q1 2025 to a low of $72000.0 in Q4 2024.